Though much of the heritability of PD has yet to be explained, the field of pharmacogenomics attempts to examine the effects of genetics on drug mechanics—specifically the interplay of dopamine transporters, receptors and enzymes critical for dopamine processing for PD. This evidence concerns the gene SLC6A3 and Parkinson disease.